ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645931 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645931; 2) Community: the network communities that were significantly associated with the response to NSC 645931; 3) Molecule: the relationships between components within communities and NSC 645931; 4) MDR: the compounds that were significantly associated with the NSC 645931.

NSC Compound Enrichment Correlation
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0392716453377535 0.054464913
NSC 48300 ANTINEOPLASTIC-48300 0.0392716453377535 -0.11972179
NSC 609815 2-Benzoylaminobenzamide, N-thiazol-2-yl- 0.0392716453377535 0.14797944
NSC 610456 Camptothecin Derivative 0.0392716453377535 -0.20151073
NSC 623128 14-FLUORO-4-DEMETHOXYDAUNORUBICIN 0.0392716453377535 -0.13782591
NSC 624401 Null 0.0392716453377535 0.01625093
NSC 632604 Bis-p-tolylediselenide 0.0392716453377535 0.15554787
NSC 634724 10,11-methylenedioxycamptothecin 0.0392716453377535 -0.10594294
NSC 652561 Null 0.0392716453377535 0.0035527136
NSC 656204 Discorhabdin G 0.0392716453377535 0.08421862
Total:73  Current:57    [First] [Prev] [Next] [Last]